Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jan 05, 2026

SELL
$0.53 - $0.71 $1,658 - $2,222
-3,130 Closed
0 $0
Q4 2024

Jan 05, 2026

BUY
$0.81 - $1.16 $2,535 - $3,630
3,130 New
3,130 $2.73 Million
Q4 2024

Jan 05, 2026

BUY
$0.81 - $1.16 $2,535 - $3,630
3,130 New
3,130 $2.73 Million

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $38.1M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Catherine Avery Investment Management LLC Portfolio

Follow Catherine Avery Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catherine Avery Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catherine Avery Investment Management LLC with notifications on news.